LAURA PETERSEN to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications LAURA PETERSEN has written about Diabetes Mellitus, Type 2.
Connection Strength
0.526
-
Impact of comorbidity type on measures of quality for diabetes care. Med Care. 2011 Jun; 49(6):605-10.
Score: 0.169
-
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
Score: 0.097
-
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs. Diabetes Care. 2022 02 01; 45(2):372-380.
Score: 0.088
-
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs. Am Heart J. 2022 06; 248:160-162.
Score: 0.088
-
Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA. 2018 Jul; 31(7):39-45.
Score: 0.069
-
General internal medicine. JAMA. 1996 Jun 19; 275(23):1811-2.
Score: 0.015